Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition

Oct 20 2003

• By The Pink Sheet

Related Content

FDA OTC Switch Policy: Key Issue Is Crafting Labeling From Public Domain

May 19 2003

Pfizer Rx-To-OTC Comments: Study Before You Switch

Jun 02 2003

Aetna Sees 80% Decrease In Rx Non-Sedating Antihistamine Use Post-Claritin

Jun 30 2003

Aventis Allegra New Prescriptions Up 9% Despite Availability Of OTC Claritin&nbsp;&nbsp;

Feb 10 2003

Schering OTC Claritin Will Launch In December Without Rx Transition Period

Dec 02 2002

Schering Consumer Strategy: Switch Claritin OTC, Establish Clarinex By DTC

Mar 11 2002

Allegra Growth Expected At 20% Annually; Generic Impact Possible In 2004

Feb 18 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window